🔎 Trials Near Me

Hem › Crohns sjukdom › Pennsylvania › Philadelphia

Kliniska studier för Crohns sjukdom i Philadelphia, PA

13 studier för Crohns sjukdom söker deltagare vid platser i och runt Philadelphia (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekryterarFas 3
  • Thomas Jefferson University Hospital ( Site 5133), Philadelphia
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekryterarFas 2
  • University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 2 till 17 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05923073

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 2/3
  • University of Pennsylvania, Philadelphia
  • Jefferson Digestive Health Institute, Philadelphia
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekryterarFas 3
  • Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

RekryterarFas 3
  • Children's Hospital of Philadelphia (CHOP), Philadelphia
Ålder 2 till 19 · Alla kön · Uppdaterad 22 sep. 2026 · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RekryterarFas 3
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 2 till 17 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05509777

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Ålder 2 till 17 · Alla kön · Uppdaterad 24 juni 2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RekryterarFas 4
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 6 till 17 · Alla kön · Uppdaterad 27 maj 2026 · NCT05781152

Precise Infliximab Exposure and Pharmacodynamic Control

RekryterarFas 2/3
  • Nemours Children's Health System-Wilmington, Wilmington · 25 mi bort
Ålder 6 till 22 · Alla kön · Uppdaterad 5 maj 2026 · NCT05660746

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Rekryterar
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 8 till 21 · Alla kön · Uppdaterad 12 juni 2025 · NCT06216899

Crohns sjukdom-studier i andra städer

Andra studier i Philadelphia

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.